Adiponectin and infarction size in subjects with and without cerebrovascular disease

Neurosciences

Volumn 14, Issue 3, 2009, Pages 245-248

  Jaleel, Anila ^a   Aqil, Saima ^a   Jaleel, Farhan ^a   Ahmad, Hakim R ^a   Zuberi, Adnan ^a   Alam, Ejaz ^b  

^a ZIAUDDIN UNIVERSITY   (Pakistan)

^b JINNAH POSTGRADUATE MEDICAL CENTRE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOADIPONECTINEMIA; MALE; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY;

EID: 68149175288     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935. (Pubitemid 32472900)
2. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004; 43: 1318-1323. (Pubitemid 38691756)
3. Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta 2004; 344: 1-12.
4. Chen MP, Tsai JC, Chung FM, Yang SS, Hsing LL, Shin SJ, et al. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 821-826. (Pubitemid 40463876)
5. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85-89. (Pubitemid 36091630)
6. Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 2005; 36: 1915-1920.
7. Diez JJ, Iglesias P. The role of novel adipocyte derived hormone adiponectin in human disease. Eur J Endocrinol 2003; 148: 293-300. (Pubitemid 36410714)
8. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adiposespecific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599. (Pubitemid 30353893)
9. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMPdependent pathway. Circulation 2000; 102: 1296-1301. (Pubitemid 30728130)
10. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103: 1057-1063. (Pubitemid 32200177)
11. Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004; 89: 2563-2568. (Pubitemid 38766332)
12. Huang ZS, Chiang TL, Lee TU. Stroke prevalence in Taiwan: Findings from the 1994 National Health Interview Survey. Stroke 1997; 28: 1579-1584
13. Bonita R. Stroke prevention: a global perspective. In: Norris JW, Hachinski V, editors. Stroke prevention. New York (NY): Oxford University Press; 2001. p. 259-274.
14. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, et al. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 2004; 43: 1318-1322. (Pubitemid 38691756)
15. Dávalos A, Castillo J, Pumar JM, Noya M. Body temperature and fibrinogen are related to early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis 1997; 7: 64-69. (Pubitemid 27129338)
16. Suominen P. Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem 2004; 50: 219-221. (Pubitemid 38125726)
17. Trinder P. Enzymatic determinations of blood glucose using glucose oxidase with an alternative oxygen acceoter. Ann Clin Biochem 1969; 6: 24-31.
18. van der Worp HB, Claus SP, Bär PR, Ramos LM, Algra A, van Gijn J, et al. Reproducibility of measurements of cerebral infarct volume on CT scans. Stroke 2001; 32: 424-434. (Pubitemid 32155229)
19. Nishimura M, Izumiya Y, Higuchi A, Shibata R, Qiu J, Kudo C, et al. Adiponectin prevents cerebral ischemic Injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 2008; 117: 216-223.
20. Matsumoto M, Ishikawa S, Kajii E. Association of adiponectin with cerebrovascular disease: a nested case-control study. Stroke 2008; 39: 323-328. (Pubitemid 351619450)
21. Bang OY, Saver JL, Ovbiagele B, Choi YJ, Yoon SR, Lee KH. Adiponectin levels in patients with intracranial atherosclerosis. Neurology 2007; 68: 1931-1937. (Pubitemid 46848626)
22. Jaleel F, Jaleel A, Rahman MA. Relationship of adiponectin, blood lipids and glycemic control in postmenopausal diabetic women with and without complication of ischemic heart disease. Clin Chim Acta 2006: 370; 76-81. (Pubitemid 44096945)
23. Sasaki M, Kawano T, Saito T, Yuzawa M, Saito T, Ikoma A, et al. Hypoadiponectinemia in patients with cerebral infarction: comparison with other atherosclerotic disorders. Am J Med Sci 2007; 333: 140-144. (Pubitemid 47181612)
24. Clark WM. Cytokines and reperfusion injury. Neurology 1997; 49 (5 Suppl 4): S10-S14. Review.
25. Clark WM. Adiponectin: spectator or player? Stroke 2005; 36: 1919-1920.